Insulin resistance and cancer-related mortality [3]

Journal of Clinical Oncology

Volumn 25, Issue 12, 2007, Pages 1628-1629

  Farooki, Azeez ^a   Schneider, Stephen H ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; VASCULOTROPIN;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER TISSUE; DIABETES MELLITUS; DRUG MECHANISM; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; MITOGENESIS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TUMOR CELL; ADOLESCENT; ADULT; CHILD; FEMALE; HYPERINSULINISM; MALE; MORTALITY; NEOPLASM; NOTE; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 34248202539     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.9637     Document Type: Letter

References (10)

1. Park SM, Lim MK, Shin SA, et al: Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation study. J Clin Oncol 24:5017-5024, 2006
2. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27:2444-2449, 2004
3. Dandona P, Mohanty P, Chaudhuri A, et al: Insulin infusion in acute illness. J Clin Invest 115:2069-2072, 2005
4. Dandona P, Aljada A, Mohanty P, et al: Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26:3310-3314, 2003
5. Dandona P, Aljada A, Mohanty P, et al: Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265, 2001
6. Kakizawa H, Itoh M, Itoh Y, et al: The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism 53:550-555, 2004
7. Ashraf A, Mick G, Meleth S, et al: Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes. J Clin Endocrinol Metab 90:4920-4923, 2005
8. Alexiewicz J, Kumar D, Smogorzewski M, et al: Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: Abnormalities in metabolism and function. Ann Intern Med 123:919-924, 1995
9. Aljada A, Ghanim H, Mohanty P, et al: Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J Clin Endocrinol Metab 87:1419-1422, 2002
10. Gæde P, Vedel P, Larsen N, et al: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003